Evidence map›Paper›PMID 20480548›Full record

ReviewCurrent opinion in lipidology2010

Acyl-coenzyme A synthetases in metabolic control.

Jessica M Ellis, Jennifer L Frahm, Lei O Li, Rosalind A Coleman

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in lipidology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 129 papers.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

129 citing papers in PubMed, 217 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. The Association ofBalkan journal of medical genetics : BJMG · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. The Effects ofACS omega · 2024
    Article
  18. ACSL3 regulates breast cancer progressionCancer biology & medicine · 2024
    Article
  19. Long-chain acyl-CoA synthetase 4-mediated mitochondrial fatty acid metabolism and dendritic cell antigen presentation.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Article
  20. Article

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jessica M EllisDepartment of Nutrition, University of North Carolina, Chapel Hill, NC 27599, USA.
Jennifer L Frahm
Lei O Li
Rosalind A Coleman
University of North Carolina at Chapel Hill · US

Funding

UNIV OF NORTH CAROLINA CLINICAL NUTRITION RESEARCH UNITP30DK056350 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SUSAN M. SMITH · 1999 to 2026
$31.6M
Yale Mouse Metabolic Phenotyping CenterU24DK059635 · NIDDK · YALE UNIVERSITY · PI SHULMAN, GERALD I · 2001 to 2015
$8.9M
Mechanisms of Lipid-Induced Hepatic Insulin ResistanceR01DK040936 · NIDDK · YALE UNIVERSITY · PI SHULMAN, GERALD I · 1989 to 2015
$5.1M
METABOLISM OF GLYCEROLIPIDS IN LIVERR01DK056598 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COLEMAN, ROSALIND ANNE · 1999 to 2016
$5.0M
Acyl-CoA Synthetase: Structure, Function and RegulationR01DK059935 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COLEMAN, ROSALIND ANNE · 2002 to 2015
$4.7M
Glycerolipid synthesis in liverR56DK056598 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COLEMAN, ROSALIND ANNE · 2017 to 2017
$228k
Nutritional and Hormonal Control of the Phosphorylation Regulation of GPAT1F32DK082099 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI FRAHM, JENNIFER LEIGH · 2009 to 2009
$41k
NIDDK NIH HHS DK056598NIDDK NIH HHS DK082099NIDDK NIH HHS DK40936NIDDK NIH HHS DK59935-S1NIDDK NIH HHS F32 DK082099NIDDK NIH HHS P30 DK056350NIDDK NIH HHS P30 DK56350NIDDK NIH HHS R01 DK040936NIDDK NIH HHS R01 DK056598NIDDK NIH HHS R01 DK059935NIDDK NIH HHS R01-DK59935NIDDK NIH HHS R56 DK056598NIDDK NIH HHS U24 DK059635NIDDK NIH HHS U24-DK59635
6 · The paper itself

Abstract

purpose of reviewThe 11 long-chain (ACSL) and very long chain acyl-coenzyme A (acyl-CoA) synthetases [(ACSVL)/fatty acid transport protein] are receiving considerable attention because it has become apparent that their individual functions are not redundant. RECENT

findingsRecent studies have focused on the structure of the acyl-CoA synthetases, their post-translational modification, their ability to activate fatty acids of varying chain lengths, and their role in directing fatty acids into different metabolic pathways. An unsettled controversy focuses on the ACSVL isoforms and whether these have both enzymatic and transport functions. Another issue is whether conversion of a fatty acid to an acyl-CoA produces an increase in the AMP/ATP ratio that is sufficient to activate AMP-activated kinase. SUMMARY: Future studies are required to determine the subcellular location of each ACSL and ACSVL isoform and the functional importance of phosphorylation and acetylation. Purification and crystallization of mammalian ACSL and ACSVL isoforms is needed to confirm the mechanism of action and discover how these enzymes differ in their affinity for fatty acids of different chain lengths. Functionally, it will be important to learn how the ACSL isoforms can direct their acyl-CoA products toward independent downstream pathways.

Indexed as

AMP-Activated Protein KinasesAnimalsBiological TransportCoenzyme A LigasesDiseaseFatty AcidsHumansAMP-Activated Protein KinasesCoenzyme A LigasesFatty Acids

Identifiers

PMID20480548
PMCPMC4040134
OpenAlexW2025604848

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.